health 1h ago
79-Year-Old Patient Receives Unapproved Experimental Weight Loss Drug Amid Trump Speculation
A patient aged 79 received an unapproved experimental weight loss drug, raising questions about access and regulatory oversight. The case has sparked widespread speculation linking the individual to former President Trump. Next, authorities may investigate the drug's distribution process and approval status.
Timeline · 6h ago
4h ago
1 article · Gizmodo
8h ago
1 article · Ars Technica Health
10h ago
1 article · Raw Story
0 Comments
Sign in to join the discussion
No comments yet
Be the first to share your thoughts
More health Stories
Breaking
Most IVF ‘add-on’ treatments lack proven effectiveness, study finds
health · 1h ago
DR Congo Ebola Cases Surpass 1,000, Killing 254
health · 5h ago
Former sports coach goes on trial in Ireland for alleged abuse of four girls in the 1970s and 1980s
health · 6h ago
Judge Rules USDA Cannot Block SNAP Purchases of Candy and Sugary Drinks
health · 3h ago
Breaking
US-Iran Peace Negotiations Advance; Deal Likely Soon, Say Sources
world · 3h ago
Breaking
SpaceX's xAI Seeks More AI Compute Deals After $1.25B Anthropic Sale
business · 1d ago